ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 345 filers reported holding ENCOMPASS HEALTH CORP in Q3 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,242,284 | -29.5% | 48,277 | -29.0% | 0.00% | 0.0% |
| Q2 2023 | $4,601,774 | +208.3% | 67,963 | +146.3% | 0.00% | +100.0% |
| Q1 2023 | $1,492,674 | -9.1% | 27,591 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $1,641,485 | +417.8% | 27,445 | +292.2% | 0.00% | – |
| Q3 2022 | $317,000 | -3.1% | 6,998 | +19.7% | 0.00% | – |
| Q2 2022 | $327,000 | -12.8% | 5,845 | +10.9% | 0.00% | – |
| Q1 2022 | $375,000 | +20.6% | 5,271 | +10.5% | 0.00% | – |
| Q4 2021 | $311,000 | -11.1% | 4,772 | +2.4% | 0.00% | – |
| Q3 2021 | $350,000 | +68.3% | 4,661 | +74.6% | 0.00% | – |
| Q2 2021 | $208,000 | -1.0% | 2,669 | +5.2% | 0.00% | – |
| Q4 2020 | $210,000 | -81.7% | 2,537 | -86.0% | 0.00% | -100.0% |
| Q2 2019 | $1,145,000 | +48.1% | 18,077 | +36.6% | 0.00% | – |
| Q1 2019 | $773,000 | +69.5% | 13,230 | +79.1% | 0.00% | – |
| Q4 2018 | $456,000 | +60.6% | 7,385 | +102.9% | 0.00% | – |
| Q3 2018 | $284,000 | – | 3,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 396,670 | $27,477,000 | 7.28% |
| Endurant Capital Management LP | 163,092 | $11,297,000 | 3.56% |
| REINHART PARTNERS, LLC. | 656,158 | $45,452,000 | 3.34% |
| RK Capital | 117,590 | $8,145,000 | 3.05% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 27,150 | $1,881,000 | 2.23% |
| Wolf Group Capital Advisors | 47,461 | $3,288,000 | 2.16% |
| Copeland Capital Management, LLC | 631,346 | $43,734,000 | 1.92% |
| Advantage Alpha Capital Partners LP | 100,722 | $6,977,000 | 1.88% |
| Rock Springs Capital Management LP | 815,000 | $56,455,000 | 1.78% |
| Kalos Management, Inc. | 61,180 | $4,237,000 | 1.54% |